Companies / Landos Biopharma, Inc.
Landos Biopharma, Inc.
LABPCIK 1785345
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | Poukalov Konstantin Director | Buy Open-market buy | Common Stock | $20.00M | +1.3M +9.35% | 14,619,728 | high |
| Feb 8, 2021 | Perceptive Advisors LLC Director | Buy Open-market buy | Common Stock | $20.00M | +1.3M +21.55% | 7,049,564 | high |
| Feb 4, 2021 | Rtw Investments, LLC 10% owner | Buy Open-market buy | Common Stock | $10.00M | +625K | 625,000 | high |
| Feb 8, 2021 | Poukalov Konstantin Director | Buy Open-market buy | Common Stock | $1.09M | +87K +0.59% | 14,768,463 | high |
| Feb 8, 2021 | Perceptive Advisors LLC Director | Buy Open-market buy | Common Stock | $1.09M | +87K +1.22% | 7,198,299 | high |
| Feb 9, 2021 | Poukalov Konstantin Director | Buy Open-market buy | Common Stock | $893.3K | +65K +0.44% | 14,834,964 | high |
| Feb 9, 2021 | Perceptive Advisors LLC Director | Buy Open-market buy | Common Stock | $893.3K | +65K +0.90% | 7,264,800 | high |
| Feb 9, 2021 | Poukalov Konstantin Director | Buy Open-market buy | Common Stock | $510.3K | +35K +0.24% | 14,869,915 | high |